SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Glanbia plc (GLAPF) trades at a trailing P/E of 27.2, forward P/E of 16.3. Trailing earnings yield is 3.67%, forward earnings yield 6.14%. PEG 1.30.
Criteria proven by this page:
- VALUE (60/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
- Forward P/E 16.3 (down from trailing 27.2) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 1.30 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 3.67% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 6.14% as earnings recover.
Overall SharesGrow Score: 64/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
60/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — GLAPF
Valuation Multiples
P/E (TTM)27.2
Forward P/E16.3
PEG Ratio1.30
Forward PEG0.24
P/B Ratio0.00
P/S Ratio1.26
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.75
Forward EPS (Est.)$1.25
Book Value / Share$0.00
Revenue / Share$16.23
FCF / Share$0.00
Yields & Fair Value
Earnings Yield3.67%
Forward Earnings Yield6.14%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.72 |
$2.85B |
$222.78M |
7.8% |
| 2017 |
$1.11 |
$2.39B |
$395.18M |
16.6% |
| 2018 |
$0.90 |
$2.39B |
$267.67M |
11.2% |
| 2019 |
$0.70 |
$3.88B |
$206.94M |
5.3% |
| 2020 |
$0.49 |
$3.82B |
$174.51M |
4.6% |
| 2021 |
$0.57 |
$4.2B |
$189.08M |
4.5% |
| 2022 |
$0.68 |
$5.64B |
$199.6M |
3.5% |
| 2023 |
$1.27 |
$5.43B |
$311.96M |
5.7% |
| 2024 |
$0.62 |
$3.84B |
$164.7M |
4.3% |
| 2025 |
$0.75 |
$4.11B |
$190.7M |
4.6% |
